These Phase 3 RCTs currently in progress and in the pipeline should provide further clarity on the long-term safety and overall effect of once-weekly subcutaneous retatrutide
GLP-1 Weight Loss Programs: Complete Beginners Guide for 2026 GLP-1 Weight Loss Programs: Complete Beginners Guide for 2026 GLP-1 weight loss programs use medications that mimic a natural hormone your body produces to regulate appetite and blood sugar, producing 10-22% average body weight loss, results previously only achievable through bariatric surgery
Rare: pancreatitis (we screen for risk factors), gallbladder issues during rapid weight loss, vision changes in diabetics
Incline Peps does not present Reta as a treatment, prescription product, medicine, supplement, cosmetic product or personal-use alternative to any licensed product
These medications are FDA-approved specifically for type 2 diabetes management or chronic weight loss, requiring prescriptions after medical evaluation and administered via weekly or daily injections
